Leverage Real-World Data
Exploring the health status from the patient’s perspective in conjugation with collecting biospecimens means you can finally bridge the gap between otherwise disparate data sources to improve decision-making processes and accelerate development. Harmonizing heterogeneous data in research is essential to generate actionable insights, and we can take that data-driven journey with you.
Our community-building approach is patient-centered and allows us to engage with patients over time to create datasets relevant to researchers, patients, providers, regulators, and payers alike.
Data Collection Capabilities
Rethink your study design to include real-world observational data collected in real-time from patient-reported outcome measures, electronic medical record information and history, custom patient surveys and questionnaires, wearable technologies, and long-term follow-up.
- Patient journey
- Patient preference
- Custom surveys and questionnaires
- Quality of life
- Burden of disease
- Impact on individuals
- Impact on families
- Wearable technologies
Medical Records & Laboratory Results
- Family history
- Treatment history
- Natural history
- Clinical genotypes and phenotypes
- Clinical testing
- Decision support tools
The biospecimens we procure are sourced from highly annotated patients who routinely engage with us. We get you the real-world evidence you need to improve the decision-making process earlier in development.
Access to more than 50,000 patients nationwide
Active, long-term patient relationships
Prospectively collected real-world data from patient surveys
Panoramic patient view harmonizes real-world evidence with biospecimen collection
Develop your own patient cohort or registry
Break team silos to increase cross-functional collaboration
We Specialize in These Conditions
Behind our therapeutic experience are patient member communities made up of more than 50,000 total members ready to advance science and medicine for the conditions they live with.
Start a data-driven journey today
Compliance & Quality Assured
Sanguine operates under an electronic informed consent process which executes 21 CFR part 11 compliant e-signatures, and Sanguine systems interacting with study participant information are HIPAA-compliant.
Sanguine utilizes two commercial, internationally-recognized IRBs for review and approval of all study protocols, specific study documentation, and study participant facing information.
Advarra is organized and operates in compliance with the US and international regulations and policies governing research with human subjects, as applicable. These include but are not limited to: US federal regulations at 21 CFR parts 50, 56, 312, and 812; US federal regulations at 45 CFR part 46; Part C, Division 5 of the Canadian Food and Drug Regulations; the Canadian Tri-Council Policy Statement 2; and the International Conference on Harmonisation (ICH) E6, Good Clinical Practice (GCP). Advarra may rely upon federal or international guidance to inform its policy development and approaches. Advarra’s IRB is registered with FDA and OHRP. Advarra’s Federalwide Assurance (FWA) has been approved by OHRP; IRB Organization (IORG) Number is 0000635, FWA Number is 00023875 and IRB Registration Number is 00000971. Please note that the IRB registration number applies for both FDA and OHRP registrations and covers all general, therapeutically focused, and country-specific panels. Advarra is fully accredited by the Association for the Accreditation of Human Research Protection Programs (AAHRPP).
WCG IRB is duly constituted, has written procedures for initial and continuing review of clinical trials; prepares written minutes of convened meetings, and retains records pertaining to the review and approval process; all in compliance with requirements of FDA regulations 21 CFR Parts 50 and 56, HHS regulations 45 CFR 46, and International Conference on Harmonization (ICH) E6, Good Clinical Practice (GCP), as applicable. WCG IRB is registered with OHRP/FDA; IRB registration number is IRB00000533, parent organization number is IORG0000432 (WCG IRB Canada registration number is IRB00002354). WCG IRB also reviews in compliance with other applicable federal and state laws and regulations governing IRBs and research with human beings. Where appropriate, WCG IRB complies with additional regulations and guidelines (such as the Canadian Tri-Council Policy Statement, Ethical Conduct for Research Involving Humans) as required in specific research jurisdictions. WCG IRB continues to be fully accredited by the Association for the Accreditation of Human Research Protection Programs (AAHRPP).